NLRP3 and hepatocellular carcinoma: Further analysis showed that NLRP3 overexpression resulted in the increase of tumor volume and decreased survival rate of HCC xenograft mice, indicating that NLRP3 overexpression counteracted the therapeutic effects of ANI on HCC.